Related Experiment Video
Updated: Dec 9, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact
Sílvia Aguiar Rosa1,2, Luís Rocha Lopes3,4,5, António Fiarresga1
1Department of Cardiology, Santa Marta Hospital, Lisbon, Portugal.
Insights
Myocardial ischemia in hypertrophic cardiomyopathy causes fibrosis and dysfunction. Evaluating coronary microcirculation indirectly is key for assessing prognosis and risk stratification.
Area of Science:
- Cardiology
- Cardiovascular Pathophysiology
Background:
- Myocardial ischemia is a key feature of hypertrophic cardiomyopathy (HCM).
- Chronic ischemia contributes to cardiac fibrosis and eventual myocardial dysfunction.
- Direct visualization of coronary microcirculation in vivo is not feasible.
Purpose of the Study:
- To highlight the significance of myocardial ischemia in HCM.
- To discuss indirect methods for evaluating coronary microcirculation.
- To emphasize the role of microcirculatory dysfunction in risk stratification.
Main Methods:
- Indirect evaluation of coronary microcirculation using echocardiography, magnetic resonance, positron emission tomography, and cardiac catheterization.
- Assessment of myocardial blood flow and coronary flow reserve.
Main Results:
- Blunted myocardial blood flow and coronary flow reserve are linked to poorer prognosis.
- Microcirculatory dysfunction is a significant finding in HCM patients.
Conclusions:
- Microcirculatory dysfunction is a crucial pathophysiological aspect of HCM.
- Assessing microcirculatory function provides valuable prognostic information.
- Microcirculatory dysfunction may enhance risk stratification beyond traditional factors in HCM.
Abstract:
Myocardial ischemia constitutes one of the most important pathophysiological features in hypertrophic cardiomyopathy. Chronic and recurrent myocardial ischemia leads to fibrosis, which may culminate in myocardial dysfunction. Since the direct visualization of coronary microcirculation in vivo is not possible, its function must be studied indirectly. Invasive and noninvasive techniques allow microcirculatory dysfunction to be evaluated, including echocardiography, magnetic resonance, positron emission tomography, and cardiac catheterization. Blunted myocardial blood flow and coronary flow reserve have been suggested to associate with unfavorable prognosis. Microcirculatory dysfunction may be one additional important parameter to take into account for risk stratification beyond the conventional risk factors.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Myocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification

